Acta Endocrinologica 2018-Jan-Mar

A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Kiungo kimehifadhiwa kwenye clipboard

B Aydin

O Aksu

H Asci

M Kayan

H Korkmaz

KIFUNGU: 31149244

DOI: 10.4183/aeb.2018.113

PMC: PMC6516607

BioSeek: 31149244

Maneno muhimu

Kikemikali

Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present a patient with a cystic macroprolactinoma who developed PA on the 16th week of cabergoline treatment.

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY.

Maneno muhimu

prolactinoma

pituitary apoplexy

kiharusi

dopamini

Kikemikali

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi